Daré Bioscience, Inc.
DARE
$2.04
-$0.04-1.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -158.33% | 94.19% | 86.56% | 91.22% | 81.89% |
| Total Depreciation and Amortization | 1,294.07% | 377.58% | 10.16% | 17.69% | 39.14% |
| Total Amortization of Deferred Charges | -47.03% | 5,428.57% | -- | -- | -- |
| Total Other Non-Cash Items | 5.06% | 9.98% | 112.12% | -12.87% | -4.16% |
| Change in Net Operating Assets | 172.03% | 277.00% | 155.55% | -497.33% | -130.97% |
| Cash from Operations | -15.15% | 122.80% | 113.88% | 78.10% | 49.70% |
| Capital Expenditure | 69.15% | -13.55% | 8.96% | -2,389.92% | -1,497.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.15% | -13.55% | 8.96% | -2,389.92% | -1,497.75% |
| Total Debt Issued | -6.57% | -6.57% | -6.57% | -6.57% | -- |
| Total Debt Repaid | -69.74% | -5.91% | -73.41% | -343.41% | -- |
| Issuance of Common Stock | -89.60% | -92.94% | -95.74% | -87.99% | 429.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.01% | -100.08% | -100.05% | -- | -- |
| Cash from Financing | -96.38% | -95.36% | -97.23% | -43.11% | 698.08% |
| Foreign Exchange rate Adjustments | -191.05% | 41.79% | -607.29% | -48.83% | 118.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -473.02% | 142.01% | 121.74% | 89.69% | 116.57% |